Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Pharmaceutical-drug

HEALTH-DRUGPRICES/
RTX7Z0TY
September 30, 2020
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House...
Washington, UNITED STATES
US House of Representatives Committee on Oversight and Reform focused on drugs prices in Washington
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the U.S. Capitol, in Washington, U.S., September 30, 2020 Greg Nash/Pool via REUTERS
HEALTH-DRUGPRICES/
RTX7Z0TQ
September 30, 2020
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation...
Washington, UNITED STATES
US House of Representatives Committee on Oversight and Reform focused on drugs prices in Washington
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the U.S. Capitol, in Washington, U.S., September 30, 2020 Greg Nash/Pool via REUTERS
HEALTH-DRUGPRICES/
RTX7Z0T9
September 30, 2020
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation...
Washington, UNITED STATES
US House of Representatives Committee on Oversight and Reform focused on drugs prices in Washington
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the U.S. Capitol, in Washington, U.S., September 30, 2020 Alex Edelman/Pool via REUTERS
HEALTH-DRUGPRICES/
RTX7Z0RM
September 30, 2020
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House...
Washington, UNITED STATES
US House of Representatives Committee on Oversight and Reform focused on drugs prices in Washington
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the U.S. Capitol, in Washington, U.S., September 30, 2020 Alex Edelman/Pool via REUTERS
HEALTH-DRUGPRICES/
RTX7Z0RL
September 30, 2020
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House...
Washington, UNITED STATES
US House of Representatives Committee on Oversight and Reform focused on drugs prices in Washington
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the U.S. Capitol, in Washington, U.S., September 30, 2020 Alex Edelman/Pool via REUTERS
HEALTH-CORONAVIRUS/USA
RTX7GF4U
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4T
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4N
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4L
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4O
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4M
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF44
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-PHARMACY/
RTS2XT0Z
January 09, 2020
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo,...
Provo, UNITED STATES
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo...
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT0X
January 09, 2020
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo,...
Provo, UNITED STATES
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo...
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT0V
January 09, 2020
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy...
Provo, UNITED STATES
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy...
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT0P
January 09, 2020
Boxes of the drug NovoLog, made by Novo Nordisk Pharmaceutical, sit on a counter at a pharmacy in Provo,...
Provo, UNITED STATES
Boxes of the drug NovoLog, made by Novo Nordisk Pharmaceutical, sit on a counter at a pharmacy in Provo...
Boxes of the drug NovoLog, made by Novo Nordisk Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT0K
January 09, 2020
Boxes of the drug Prevnar 13, made by Pfizer Pharmaceutical, sit on a counter at a pharmacy in Provo,...
Provo, UNITED STATES
Boxes of the drug Prevnar 13, made by Pfizer Pharmaceutical, sit on a counter at a pharmacy in Provo
Boxes of the drug Prevnar 13, made by Pfizer Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT0I
January 09, 2020
A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo,...
Provo, UNITED STATES
A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo...
A pharmacist holds a box of the drug Victoza, made by Novo Nordisk Pharmaceutical, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
HEALTH-PHARMACY/
RTS2XT03
January 09, 2020
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in...
Provo, UNITED STATES
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in...
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
SERVIER-MEDIATOR/TRIAL
RTX748TA
September 23, 2019
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator...
Paris, France
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator...
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator drug case, one of the countryÕs biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748T8
September 23, 2019
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator...
Paris, France
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator...
Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator drug case, one of the countryÕs biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748SI
September 23, 2019
Claude Griscelli, Professor of Pediatrics and Medical Genetics and Herve Temime, lawyer of pharma group...
Paris, France
Claude Griscelli, Professor of Pediatrics and Herve Temime, lawyer of pharma group Servier, arrive to...
Claude Griscelli, Professor of Pediatrics and Medical Genetics and Herve Temime, lawyer of pharma group Servier, arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748IT
September 23, 2019
Lawyers arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical...
Paris, France
Lawyers arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical...
Lawyers arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748GQ
September 23, 2019
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case,...
Paris, France
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case,...
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748GP
September 23, 2019
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case,...
Paris, France
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case,...
Nathalie Carrere, lawyer of pharma group Servier, arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX748AA
September 23, 2019
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator...
Paris, France
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator...
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7489N
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7489C
September 23, 2019
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of...
Paris, France
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of...
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7489B
September 23, 2019
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of...
Paris, France
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of...
Olivier Laureau, President of the Servier Group, talks to journalists before the start of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74888
September 23, 2019
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug...
Paris, France
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug...
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74880
September 23, 2019
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug...
Paris, France
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug...
Lawyer Jean-Christophe Coubris talks to journalists before the start of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7485B
September 23, 2019
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator...
Paris, France
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator...
French doctor Irene Frachon talks with Gaetan, a victim, as they arrive to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74829
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74827
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74822
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7481Z
September 23, 2019
French doctor Irene Frachon is surrounded by journalists as she arrives to attend the trial of the Mediator...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon is surrounded by journalists as she arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7481C
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7480X
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7480W
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7480S
September 23, 2019
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
Paris, France
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s...
French doctor Irene Frachon arrives to attend the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX747BL
September 23, 2019
A man enters the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
Paris, France
A man enters the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
A man enters the courtroom before the opening of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7475N
September 23, 2019
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
Paris, France
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX7475L
September 23, 2019
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
Paris, France
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s...
A view shows the courtroom before the opening of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
SERVIER-MEDIATOR/TRIAL
RTX74752
September 23, 2019
A view shows the court before the opening of the trial of the Mediator drug case, one of the country’s...
Paris, France
A view shows the court before the opening of the trial of the Mediator drug case, one of the country’s...
A view shows the court before the opening of the trial of the Mediator drug case, one of the country’s biggest pharmaceutical scandals, at the courthouse in Paris, France, September 23, 2019. REUTERS/Charles Platiau
BRITAIN-EU/MEDICINES
RTS2M99G
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
BRITAIN-EU/MEDICINES
RTS2M99B
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
BRITAIN-EU/MEDICINES
RTS2M999
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
USA-ABORTION/PILLS
RTS2JUOE
June 27, 2019
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this...
Provo, UNITED STATES
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this...
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this picture illustration taken June 19, 2019 in Provo, Utah, U.S., June 19, 2019. REUTERS/George Frey/Illustration
USA-ABORTION/PILLS
RTS2JUMQ
June 27, 2019
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
Provo, UNITED STATES
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JUMI
June 27, 2019
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
Provo, UNITED STATES
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JUMD
June 27, 2019
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
Provo, UNITED STATES
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JUM5
June 27, 2019
A pharmacist poses with pills of the drug Misoprostol, made by Lupin Pharmaceuticals, in his hand at...
Provo, UNITED STATES
A pharmacist poses with pills of the drug Misoprostol, made by Lupin Pharmaceuticals, in his hand at...
A pharmacist poses with pills of the drug Misoprostol, made by Lupin Pharmaceuticals, in his hand at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JUM0
June 27, 2019
A pharmacist drops pills of the drug Misoprostol, made by Lupin Pharmaceuticals, into a digital pill...
Provo, UNITED STATES
A pharmacist drops pills of the drug Misoprostol, made by Lupin Pharmaceuticals, into a digital pill...
A pharmacist drops pills of the drug Misoprostol, made by Lupin Pharmaceuticals, into a digital pill counting and photo machine at a pharmacy in Provo Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JULZ
June 27, 2019
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
Provo, UNITED STATES
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in...
A pharmacist shows a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
USA-ABORTION/PILLS
RTS2JULX
June 27, 2019
A bottle and pills of the drug Misoprostol, made by Lupin Pharmaceuticals, sit in a counting tray at...
Provo, UNITED STATES
A bottle and pills of the drug Misoprostol, made by Lupin Pharmaceuticals, sit in a counting tray at...
A bottle and pills of the drug Misoprostol, made by Lupin Pharmaceuticals, sit in a counting tray at a pharmacy, in this picture illustration taken June 19, 2019, in Provo, Utah, U.S., June 19, 2019. REUTERS/George Frey/Illustration
USA-ABORTION/PILLS
RTS2JULW
June 27, 2019
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this...
Provo, UNITED STATES
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this...
Bottles of the drug Misoprostol, made by Lupin Pharmaceuticals, sit on a shelf at a pharmacy, in this picture illustration taken June 19, 2019 in Provo, Utah, U.S., June 19, 2019. REUTERS/George Frey/Illustration
USA-ABORTION/PILLS
RTS2JULV
June 27, 2019
A pharmacist removes a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, from a shelf at...
Provo, UNITED STATES
A pharmacist removes a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, from a shelf at...
A pharmacist removes a bottle of the drug Misoprostol, made by Lupin Pharmaceuticals, from a shelf at a pharmacy in Provo, Utah, U.S., June 19, 2019. Picture taken June 19, 2019. REUTERS/George Frey
RELIGION-RAMADAN/AZERBAIJAN
RTX6X6QL
May 30, 2019
Turbah, a piece of wood or clay tablets which are used by shi'ite Muslims on the ground during prayers...
Baku, Azerbaijan
Turbah, a piece of wood or clay tablets which are used by shi'ite Muslims on the ground during prayers...
Turbah, a piece of wood or clay tablets which are used by shi'ite Muslims on the ground during prayers are seen at Juma Mosque in the old town of Baku, Azerbaijan May 30, 2019. REUTERS/Amr Abdallah Dalsh
PORTUGAL-CANNABIS/TILRAY
RTX6T19C
April 24, 2019
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede, Portugal April 24, 2019. REUTERS/Rafael...
CANTANHEDE, Portugal
Cannabis plants grow inside the Tilray factory in Cantanhede
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede, Portugal April 24, 2019. REUTERS/Rafael Marchante
PORTUGAL-CANNABIS/TILRAY
RTX6T194
April 24, 2019
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede, Portugal April 24, 2019. Picture...
CANTANHEDE, Portugal
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede, Portugal April 24, 2019. Picture taken with a zoom burst. REUTERS/Rafael Marchante
Sort by
Display
Items per page
Page
of 31